Jane Street’s Tango Therapeutics TNGX Stock Holding History

Jane Street’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$686K	Buy	32,800 +3,200	+11%	+$44.5K	﹤0.01%	7313
2025 Q4	$262K	Buy	+29,600	New	+$255K	﹤0.01%	9132

Other funds holding TNGX

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

TGI

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Jane Street's TNGX Position: Q2 2025 in Review

Jane Street sold out of Tango Therapeutics (TNGX) in Q2 2025, closing a stake of 352,897 shares — an estimated $483K sold.

Jane Street first reported a position in TNGX in Q1 2022 and held it in 9 quarters. The position peaked at $854K in Q4 2023. 115 funds tracked by Wall St. Rank hold TNGX as of Q2 2025.

Jane Street reported no remaining Tango Therapeutics position as of Q2 2025 after selling out during the quarter.
Jane Street sold 352,897 Tango Therapeutics shares in Q2 2025, an estimated $483K.
Jane Street first reported a position in Tango Therapeutics in Q1 2022 and held it in 9 quarters.
Jane Street's Tango Therapeutics position peaked at $854K in Q4 2023.
115 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2025.

Based on Jane Street's 13F filing for Q2 2025, filed 14 Aug 2025.